Front Page News

Cure SMA Welcomes New Medical Advisory Council Committee Members

March 1, 2018
Posted in , ,

We are excited to welcome 20 new members to our Medical Advisory Council (MAC). These clinicians represent eleven specialties, including specialties that were not previously […]

Read More ›

SMA Newborn Screening Moves Forward in Indiana, Ohio and Georgia

February 28, 2018
Posted in , ,

The spinal muscular atrophy community is celebrating significant progress toward adding SMA to newborn screening panels in several states. Indiana Poised to Become the Fourth […]

Read More ›

#ShowYourRare and Raise SMA Awareness on World Rare Disease Day

February 28, 2018
Posted in , ,

Rare Disease Day is today, February 28! And we’re calling on our entire spinal muscular atrophy community to get involved. Rare Disease Day is important […]

Read More ›

Last Week’s Webinar on Treatment Access and Clinical Trials Now Available

February 23, 2018
Posted in , ,

A recording of last week’s webinar updating the community on treatment access and clinical trials is now available online. A PDF of the webinar presentation […]

Read More ›

Cure SMA Receives Generous Gift from the Weisman Family Foundations

February 22, 2018
Posted in ,

The Weisman Family Foundations recently awarded $65,800 to Cure SMA, in order to further new scientific research, and to help provide access to treatments, clinical […]

Read More ›

Phase 2 Clinical Trial Results for CK-2127107 Expected in Second Quarter of 2018

February 21, 2018
Posted in , ,

Cytokinetics is currently conducting a Phase 2 clinical trial of CK-2127107 – now referred to by the generic name, reldesemtiv – which is designed to […]

Read More ›

Cure SMA Receives Generous Gift

February 16, 2018
Posted in , ,

Cure SMA is extremely pleased to announce a generous $620,000 gift has been made to the organization. The donation was made anonymously in honor of […]

Read More ›

Biogen Releases Statement on CHERISH Data and Plans for New Clinical Research

February 14, 2018
Posted in , ,

Biogen has provided the following community statement on the final results from CHERISH, a Phase 3 study of SPINRAZA.  Dear Members of the SMA community, […]

Read More ›

Additional Funding for SMA Care Centers Announced

February 14, 2018
Posted in , ,

Cure SMA is pleased to announce the second round of grants from $450,000 in funding, awarded to a total of 9 sites to help increase […]

Read More ›

Cure SMA Announces Local Educational Symposiums in 16 US Locations

February 12, 2018
Posted in , ,

Cure SMA is pleased to announce a slate of one-day local symposiums, beginning late spring and continuing into fall 2018. The symposiums will be held […]

Read More ›
Scroll to Top